From: Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study)
Characteristic
Value
Age (years)
55.2 ± 15.5
Gender (M/F)
13/7
Body Mass Index (Kg/m2)
25.1 ± 5.4
Diabetes Duration (years)
4.5 ± 3.7
HbA1c (%)
7.9 ± 0.7
Treatment
None (diet/exercise)
12
SU
8